Complications and clinical outcome of hepatic artery embolisation in patients with hereditary haemorrhagic telangiectasia
暂无分享,去创建一个
M. Gebel | A. Chavan | H. Seifert | T. Kirchhoff | H. Barg‐Hock | B. Schmuck | R. Raab | L. Luthe
[1] J. Saurin,et al. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. , 2012, JAMA.
[2] G. Inama,et al. Natural History and Outcome of Hepatic Vascular Malformations in a Large Cohort of Patients with Hereditary Hemorrhagic Teleangiectasia , 2011, Digestive Diseases and Sciences.
[3] J. Saurin,et al. Long‐term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: A single‐center study , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[4] A. Guttmacher,et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia , 2009, Journal of Medical Genetics.
[5] C. Shovlin,et al. Hereditary haemorrhagic telangiectasia: a clinical and scientific review , 2009, European Journal of Human Genetics.
[6] L. Adams,et al. Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[7] G. Garcia‐Tsao. Liver involvement in hereditary hemorrhagic telangiectasia (HHT). , 2007, Journal of hepatology.
[8] Robert I. White,et al. Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations , 2006, Liver international : official journal of the International Association for the Study of the Liver.
[9] W. Fischbach,et al. Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab , 2006, Annals of Hematology.
[10] J. Belghiti,et al. Liver Transplantation for Hereditary Hemorrhagic Telangiectasia: Report of the European Liver Transplant Registry , 2006, Annals of surgery.
[11] M. Manns,et al. Hepatic artery embolization for treatment of patients with hereditary hemorrhagic telangiectasia and symptomatic hepatic vascular malformations , 2004, European Radiology.
[12] D. Samuel,et al. [Liver transplantation for intrahepatic Rendu-Osler-Weber's disease: the Paul Brousse hospital experience]. , 2002, Gastroenterologie clinique et biologique.
[13] U. Settmacher,et al. Liver transplantation for treatment of intrahepatic Osler's disease: first experiences. , 2001, Transplantation.
[14] D. Jain,et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. , 2000, The New England journal of medicine.
[15] J. Korzenik,et al. Fatal outcome after embolotherapy for hepatic arteriovenous malformations of the liver in two patients with hereditary hemorrhagic telangiectasia. , 2000, Journal of vascular and interventional radiology : JVIR.
[16] A. Guttmacher,et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). , 2000, American journal of medical genetics.
[17] H. Schlitt,et al. Hereditary hemorrhagic telangiectasia: effective protocol for embolization of hepatic vascular malformations--experience in five patients. , 1998, Radiology.
[18] Y. Becker,et al. Liver transplantation as definitive therapy for complications after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia. , 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.